The global clinical analyzer market is projected to reach USD 7.03 billion by 2028 from USD 4.44 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period. The increasing adoption of high-throughput and point-of-care lab testing in healthcare settings along with rising awareness on noninvasive tests are expected to drive the growth of this market during the forecast period.
A clinical analyzer is an analytical instrument that provides laboratory quality testing for medical diagnosis and monitoring. It has the capability to test different biological fluids, such as blood serum, urine, or saliva. Clinical analyzers are capable of testing many chemical properties in these fluids at once by utilizing tests like gas chromatography, high-performance liquid chromatography (HPLC), electrophoresis, fluorescent spectroscopy, or immunoassays. Some examples of clinically used analyzers include hematology analyzers which measure red and white cells and platelets in whole blood; chemistry analyzers which measure substances including glucose, urea nitrogen (BUN) creatinine ions/creatinine ratio in the human body; and urinalysis analyzers which measure the urine volume, color, pH and levels of protein, glucose or ketones.
On the basis of type, the clinical analyzer is segmented into analyzers using standard clinical chemistry analysis and analyzers using integrating clinical chemistry analysis.
Analyzers using standard clinical chemistry analysis are devices that measure the concentration of various metabolites and other substances in bodily fluids, such as blood or urine. These analyzers can be used to diagnose a wide range of medical conditions including anemia, kidney disease, diabetes mellitus type I and II, liver diseases (such as hepatomegaly), heart problems, etc. They use enzymatic reaction for detection but do not require any instrumentation like spectrophotometric detectors or chromatography columns.
The analyzers using integrating clinical chemistry analysis are popular for their ability to measure multiple components in a single sample. They can provide accurate results with minimum time and effort, which is crucial when performing multiple tests on different samples simultaneously or fast-turnaround lab testing (e.g., emergency room). These instruments typically use immunoassay technology, such as enzyme-linked immunosorbent assay (ELISA) test kits that detect the presence of substances through an antibody-antigen reaction. In this method, antibodies bind only to specific antigens; therefore, specificity is ensured while reducing the risk of cross-reactivity due to false positives.
On the basis of application, the clinical analyzer is segmented into small point-of-care clinics and high throughput clinical labs.
The usage of the clinical analyzers in small point-of-care clinics is dependent on their requirements. For example, if they are looking for a simple blood glucose test or a quick urine exam and want to have this done within minutes then the available options should be capable enough to offer speedy diagnostics at an affordable price range. On the other hand, when it comes to laboratories where more than 2000 tests may need to be carried out simultaneously then there are specialized diagnostic machines that can handle such workload with ease. In addition, different types of testing needs require specific analyzer configurations which again depend upon things like the number of samples required per day as well as turnaround time expectations.
The use of high-throughput clinical labs is largely used for the diagnosis and treatment of cancer. There are various types of cancers that require different procedures to be taken, some more complex than others. Currently, there is a shortage of oncology specialists in many countries with an aging population (as they retire). This has led to increased demand for laboratories capable of processing large numbers of samples quickly - as well as establishing international partnerships between institutes that offer training courses and those seeking staff from abroad. A hospital might have a dozen or so laboratory technicians running around performing tests on specimens all day long, but this level will not suffice if it needs hundreds or thousands instead. The need for such facilities, where specialization can take place at scale, is enormous.
On the basis of region, the global clinical analyzer market is segmented into North America, Europe, Asia-Pacific, and Middle East & Africa. North America is expected to be the largest market for clinical analyzers owing to the high adoption of new diagnostic technologies in hospitals as well as favorable reimbursement policies by payers which are driving investments from technologically advanced enterprises.
The growth factors of the market are due to the growing patient population and increasing demand for advanced clinical analyzers. The key factor driving the global clinical analyzer market is increased need among healthcare providers, pharmaceutical companies, hospitals, and other point-of-care labs for better quality diagnosis in terms of accuracy & precision. Cancer, heart disease, and respiratory disorders have been major drivers behind the increased adoption of lab procedures that require precise analysis at a microscopic level, due to their accuracy and sensitivity to changes over time or location - both qualities that cannot be matched by manual labor alone. Additionally, there is an increase in awareness among people who want to know more about their health status through regular checkups from qualified professionals on a personal basis.
Up Market Research published a new report titled “Clinical Analyzer Market research report which is segmented by Types (Analyzers Using Standard Clinical Chemistry Analysis, Analyzers Using Integrating Clinical Chemistry Analysis), By Applications (Small Point-Of-Care Clinics, High-Throughput Clinical Labs), By Players/Companies Abbott Laboratories, Randox Laboratories, Thermo Fisher Scientifc, Siemens, Danaher, Mindray Medical International, ELITechGroup”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
|Report Attributes||Report Details|
|Report Title||Clinical Analyzer Market Research Report|
|By Type||Analyzers Using Standard Clinical Chemistry Analysis, Analyzers Using Integrating Clinical Chemistry Analysis|
|By Application||Small Point-Of-Care Clinics, High-Throughput Clinical Labs|
|By Companies||Abbott Laboratories, Randox Laboratories, Thermo Fisher Scientifc, Siemens, Danaher, Mindray Medical International, ELITechGroup|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||214|
|Number of Tables & Figures||150|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Analyzers Using Standard Clinical Chemistry Analysis, Analyzers Using Integrating Clinical Chemistry Analysis and By Application Small Point-Of-Care Clinics, High-Throughput Clinical Labs.
Some of the companies that are profiled in this report are:
Clinical Analyzer Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Clinical Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Clinical Analyzer Market Report:
Some other reports from this category!